An attempt is being made to determine the relation of the serum lipids to the progression of human atherosclerosis. The serum lipids are estimated serially during life and are compared with the degree of atherosclerosis found post mortem. The findings in the first 50 fatalities in the series of 800 patients are reported. The results make a poor case for the effect of derangements of the serum lipids on the disease process. Elevation of the cholesterol-phospholipid ratio has the most suggestive atherogenic effect, but this is not consistent. The total serum cholesterol and the Sf 12-20 and 20-100 lipoproteins show no significant relationships.
R ECENT observations in the field of lipid chemistry have suggested that derangements of some of the serum lipids may be responsible for the progression of the human atherosclerotic process. The derangements, most under suspicion at the moment, are (1) an elevation of the total serum cholesterol, (2) an increase in the serum cholesterol-phospholipid ratio and (3) an increase in the concentration of certain serum lipoprotein molecules, particularly those in the Sf [12] [13] [14] [15] [16] [17] [18] [19] [20] class.
Any or all of these derangements may well have a bearing on the pathogenesis of human atherosclerosis, but to establish this relationship is difficult. The stumbling block lies in the fact that the diagnosis of the disease, in its various degrees, is often impossible except on the autopsy table. The only reasonably reliable clinical manifestations are the signs and symptoms of coronary artery disease; but even here there are fallacies. It is fair to assume that patients with angina pectoris or demonstrable cardiac infarcts are probably suffering from a moderate or severe grade of atherosclerosis, but it does not follow that those without signs or symptoms (the so-called normal controls) do not harbor atherosclerosis of a similar degree. Asymptomatic coronary sclerosis is in fact extremely common. According to Page,' "Most investigators in the field of atheroscle- rosis quite confidently state that most adults have more or less of this condition. Yet these people with more or less atherosclerosis are the normal controls."
Thus, in order to establish a relationship between disorders of the serum lipids and an acceleration of the atherosclerotic process, a method more critical than clinical diagnosis is needed for the evaluation of the disease. We suggest that a more accurate procedure is to compare the degree of atherosclerosis seen at autopsy with the serum lipid picture, the latter being determined serially during life. Several points must be borne in mind in carrying out an assessment of this kind. Since atherosclerosis is a disease which may take years to develop and may persist for some time after the causative agent has ceased to act, the serial determinations of the serum lipids should be made over long periods.2 Also, technics should be devised for measuring the degree of atherosclerosis at autopsy that are more accurate than the crude methods of morphological grading in general use today. And finally, allowances may have to be made for a possible regression of atherosclerosis, terminally, from wasting disease states. 3 With these requirements in mind, we are presently assessing the importance of the serum lipids in the progression of atherosclerosis in approximately 800 patients who are permanently confined to our hospital. The serum lipid levels are being determined serially in these patients during life, and these antemortem findings are then compared with the mor- '.t c.
-c. First of all, it might be advisable to defend our use of psychotic patients in the present evaluation. An essential feature of our experimental procedure was that the patients be under control in hospital for long periods, and that, when they die, we could carry out a rather specialized type of pathologic examination. Inmates of psychiatric institutions would seem to fit these requirements best. However, it might be claimed that psychotic patients differ in many ways from members of the general population. In particular, it has been argued that they are prone to nutritional defects and metabolic derangements. These claims, of course, are true. We are even willing to concede that their serum lipid patterns may differ from those of nonpsychotic individuals. But our aim is not to study the mechanism of derangement of the serum lipids in psychotics; rather it is to evaluate the effect of these derangements, produced in any way, on the progression of atherosclerosis. We submit that the use of psychotics is just as valid in this respect as the use of diabetics. For those who are still sceptical, it should be mentioned that our series of 800 subjects includes 100 nonpsychotic subjects who are confined to the hospital for domiciliary care. Four of these have already died and they showed no difference in the general pattern from that shown in psychotics. We would stress also that almost all of the 46 psychotics in the present study were suffering from stages of psychosis that did not appreciably affect their physical health. They were ambulatory and fairly well nourished until the onset of their terminal illness.
It must also be admitted that there is no completely satisfactory way of assessing the severity of atherosclerosis in autopsy material.11 Several methods have been suggested, including an estimate of the number and size of the lesions, a measurement of the thickness of the largest plaques, the amount and concentration of lipid and of calcium deposited in the arterial wall, the extent of atheromatous ulceration, and the degree of stenosis of the arterial lumen. Any one of these is far superior to clinical methods of assessment, but none is without error. For example: a solitary stenosing plaque in a small artery will have more effect on functional efficiency than many plaques of similar size in a larger vessel; the amount of lipid is not always increased in severe grades of the disease, the accelerating factor here being fibrosis rather than atheroma; the calcium deposition is sometimes just as much a result of aging as it is of progressive sclerosis; and necrosis with ulceration may destroy the apex of a large plaque, thus giving a fallacious result when the thickness of the plaque is measured. The situ- and of Ladd and co-workers."4 Our analysis, using morphologic grading as an index of severity of sclerosis, tends to confirm this relationship: although statistically significant in only one type of artery, the coronaries, the trend to an increasing antemortem cholesterolphospholipid ratio with increasing severity of disease is evident in all four types of arteries (see table 2) . Analyses based on the other five indices, however, give only one statistically significant correspondence between this ratio and a measure of severity of disease in femoral arteries using lipid concentration as an indexand in none of these analyses is the trend in cholesterol-phospholipid ratios consistent in all four types of arteries. The picture, which we regard as an extremely interesting one, may be clarified when our series is extended.
The importance of the elevation of the Sf 0-12 class of lipoproteins, which was noted in two of our comparisons, is even more difficult to evaluate. This class of lipoproteins seems to be the one that is considered least significant either in experimental atherosclerosis or in the human disease evaluated by clinical methods. We are, therefore, inclined to view our two isolated significant relationships with some scepticism since they occur in only 2 out of 23 comparisons and since there is no indication of a consistent trend in all four types of arteries in any one analysis. One can be more dogmatic, however, regarding the Sf [12] [13] [14] [15] [16] [17] [18] [19] [20] and Sf 20-100 classes of lipoproteins. Neither of these showed any relationship to the degree of atherosclerosis in any artery, measured in any of six different ways. Their diagnostic importance for occult human atherosclerosis must therefore be taken as unproved in this preliminary series.
No conclusive information has been obtained regarding the possibility that aging or terminal loss in weight might invalidate the results of our various statistical analyses. It has been suggested, very properly, that an artery which has been exposed to the effects of an abnormal serum lipid level for 70 years will be more apt to show an acceleration of disease than one which is exposed to a similar abnormality for only 50 years. Accordingly, we have compared the severity of atherosclerosis in the four arteries, as measured in six different ways, with the ages of the 50 individuals in our series. In only seven, out of the 23 comparisons made in this way, was age significantly related to the progression of the disease. And it was noteworthy that the degree of atherosclerosis in the coronary arteries, measured in six ways, was not affected statistically by age. The artery that did show the greatest effect in this regard was the femoral (in four out of six comparisons).
Evidence of regression of the atherosclerotic process in terminal diseases of a wasting type was not conclusive in our series. Wilens3 has stated that atherosclerosis is more severe in obese individuals than in those who are poorly nourished. It is therefore possible that absorption of the lipid in atherosclerotic plaques, with consequent reduction in the size of the plaques, might occur in the course of wasting diseases. The cachexia that results from cancer is an example of this theoretical effect. We have compared both the lipid concentration in the coronary arteries, and the morphological grade of coronary sclerosis, with the terminal change in body weight from the usual weight for each of the 50 cases. The results are given in tables 7 and 8. There may be some significance in the Le resultatos non representa un bon supporto pro le these que disrangiamento del lipidos seral affice le processo pathologic. Le elevation del proportion de cholesterol a phospholipido es le plus probabilemente interpretabile como apte a exercer un effecto atherogenic, sed isto non es uniforme. Le totales de cholesterol seral e le lipoproteinas Sf 12-20 e 20-100 non monstra interrelationes significative.
